Tumor-infiltrating lymphocytes (TIL) is a heterogeneous lymphocyte group that has an anti-tumor effect on the tumor, and CD8+ T cells are the main effector cells (Farhood et al., 2019; Raskov et al., 2021). This evidence concerns the gene CD8A and neoplasm.